ArticlemAbs

Conjugation of DM1 to anti-CD30 antibody has potential antitumor activity in CD30-positive hematological malignancies with lower systemic toxicity.

Yijun Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.